Treatment with paliperidone palmitate according to clinical practice upon admission to acute units: shadow study

被引：0
|
作者：
Parellada, E. [1 ]
Bioque, M. [1 ]
Herrera, B. [2 ]
Garcia Dorado, M. [2 ]
机构：
[1] Hosp Clin Barcelona, Unitat Esquizofrenia Clin, Barcelona, Spain
[2] Janssen, Med Affairs Dept, Madrid, Spain
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70882-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.3.d.049
引用
收藏
页码：S551 / S551
页数：1
相关论文
共 50 条
  • [41] Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis
    Taro Kishi
    Kenji Sakuma
    Nakao Iwata
    Translational Psychiatry, 12
  • [42] Use of palmitate of paliperidone 1-monthly in patients <40 years old: Results of real clinical practice
    Campos, J. A.
    Docasar, L.
    Seoane, A. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S535 - S535
  • [43] Clinical experiences with 6-monthly paliperidone palmitate beyond the diagnosis of schizophrenia. A retrospective study
    Lopez, S. Benavente
    Mendoza, S. Bolano
    Gonzalez, A. Parra
    Fernandez, A. Lara
    Nevado, A. Herencias
    Garcia, E. Baca
    EUROPEAN PSYCHIATRY, 2023, 66 : S489 - S489
  • [44] Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study
    Naber, D.
    Hansen, K.
    Forray, C.
    Baker, R. A.
    Sapin, C.
    Beillat, M.
    Peters-Strickland, T.
    Nylander, A. G.
    Hertel, P.
    Andersen, H. Steen
    Eramo, A.
    Loze, J. Y.
    Potkin, S.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [45] Platelet Count upon Acute Hospital Admission to Internal Medicine Units Is a Predictor of Mortality in Adults: A Danish Cohort Study
    Moulis, Guillaume
    Christiansen, Christian Fynbo
    Darvalics, Bianka
    Andersen, Ina Trolle
    Sorensen, Henrik Toft
    Norgaard, Mette
    BLOOD, 2018, 132
  • [46] Gray matter volumes may predict the clinical response to paliperidone palmitate long-acting in acute psychosis: A pilot longitudinal neuroimaging study
    Altamura, A. Carlo
    Delvecchio, Giuseppe
    Paletta, Silvia
    Di Pace, Chiara
    Reggiori, Alessandra
    Fiorentini, Alessio
    Mirabile, M. Donatella
    Paoli, Riccardo A.
    Cinnante, Claudia
    Triulzi, Fabio
    Mauri, Massimo C.
    Brambilla, Paolo
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2017, 261 : 80 - 84
  • [47] Clinical experiences with 6-monthly paliperidone palmitate beyond the diagnosis of schizophrenia. A retrospective study
    Benavente Lopez, S.
    Bolano Mendoza, S.
    Parra Gonzalez, A.
    Lara Fernandez, A.
    Herencias Nevado, A.
    Baca Garcia, E.
    EUROPEAN PSYCHIATRY, 2023, 66 : S489 - S489
  • [48] Prevalence of thrombocytopenia upon acute hospital admission: A study in Denmark
    Moulis, Guillaume
    Christiansen, Christian Fynbo
    Darvalics, Bianka
    Sorensen, Henrik Toft
    Norgaard, Mette
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 376 - 376
  • [49] Patients' perspectives on three-monthly administration of antipsychotic treatment with paliperidone palmitate - a qualitative interview study
    Rise, Marit B.
    Stolan, Liv Os
    Erdner, Anette
    Hedberg, Berith
    Stahl, Katja
    Riise, Jesper
    Jedenius, Erik
    Mollerhoj, Jette
    NORDIC JOURNAL OF PSYCHIATRY, 2021, 75 (04) : 257 - 265
  • [50] Paliperidone palmitate 3 month formulation for the treatment of schizophrenia: a 36 months follow-up study
    Romero Guillena, S. L.
    Plasencia Garcia De Diego, B. O.
    EUROPEAN PSYCHIATRY, 2020, 63 : S548 - S548
12345